You are here
Drugs to Elevate Enkephalin as Novel Opiate Analgesics
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43DA018007-01
Agency Tracking Number: DA018007
Amount:
$157,550.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
AMERICAN LIFE SCIENCE PHARMACEUTICALS
6540 LUSK BLVD, STE C162
SAN DIEGO, CA
92121
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: TERRY Reisine
Phone: (310) 839-6268
Email: TREISINE@AOL.COM
Phone: (310) 839-6268
Email: TREISINE@AOL.COM
Business Contact
Phone: (858) 875-1520
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Pain is a serious, debilitating condition that is under-treated because of the dose-limiting side effects of currently used opiate drugs such as morphine. Enkephalin is an endogenous opiate peptide, which induces analg
* Information listed above is at the time of submission. *
